NCT03710187View on ClinicalTrials.gov

HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

September 27, 2019

Study Completion Date

September 27, 2019

Conditions
Septic Shock
Interventions
DRUG

Hydrocortisone

Hydrocortisone 50 mg IV Q6h

Trial Locations (1)

37920

University of Tennessee Medical Center, Knoxville

All Listed Sponsors
lead

University of Tennessee Medical Center

OTHER

NCT03710187 - HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients | Biotech Hunter | Biotech Hunter